A new study published today in the Proceedings of the National Academy of Sciences (PNAS), an international research team led jointly by scientists from the Weizmann Institute of Science and Washington University School of Medicine in St. Louis presents the first use of CAR-T in the treatment of Alzheimer’s disease.
